Brad Williamson APSS?
Update this Profile
Brad Williamson APSS, Counselor/Therapist
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Brad Williamson APSS

Counselor/Therapist | Addiction (Substance Use Disorder)

308 W DIXIE AVE ELIZABETHTOWN KY, 42701
Write A Review

About

Brad Williamson is an Addiction Medicine Counselor in ELIZABETHTOWN, KY. Brad evaluates patients using many different procedures, in order to determine what treatments must be carried out in order to properly assess their symptoms. Addiction Medicine counselors provide patient care and consultation for each patient and their families.

Provider Details

MaleEnglish

Brad Williamson APSS's Practice location

308 W DIXIE AVE -
ELIZABETHTOWN, KY 42701
Get Direction
New patients: 270-268-7021

Brad Williamson APSS's reviews

(0)
Write Review

Recommended Articles

  • 5 Tips On Living With Lupus

    Lupus is a chronic, autoimmune disease that can cause harm anywhere in the body. It can manifest in your organs, joints or even skin. When affected by lupus, your immune systems does not work not as intended. Your immune system is supposed to combat bacteria, germs and viruses. The body is protected...

  • What Is the Cause of an Underactive Thyroid Gland?

    Gaining weight? Feeling colder? Feeling depressed? Hypothyroidism could be the reason behind it.What is hypothyroidism?Also known as low thyroid or underactive thyroid, hypothyroidism is characterized by underactive thyroid glands that fail to produce an adequate amount of thyroid hormones. These...

  • Sexual and Reproductive Health Care in Young Women with Cystic Fibrosis

    The Journal of Cystic Fibrosis has published recent study results on research into the sexual and reproductive health care in young women with cystic fibrosis.This study compared the sexual and reproductive health (SRH) care of those with CF to the general U.S. population. Both groups of women were...

  • FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

    On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...

  • Study Attempts to Connect the Dots Between Menopause and Alzheimer's

    According to a study, there is a correlation between menopause and Alzheimer's disease that involves the changes in the metabolic system, such as the loss of estrogen, increasing the chance of developing Alzheimer's. Apparently, menopause is actually the second major risk factor, after old age, for...

  • The Difference Between Parkinson’s and Parkinsonism

    Parkinson’s and Parkinsonism sound the same, and they are very similar. Parkinsonism is defined as several neurological disorders causing movement problems, but there are differences. ...